Chong Kun Dang Pharmaceutical Corp.
Research Chong Kun Dang Pharmaceutical Corp. (185750.KS) on Bullrun: market cap KRW 874.89B, dividend yield 0.8%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker185750.KS
- ExchangeKS
- CountrySouth Korea
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyKRW
- Market capKRW 874.89B
- Dividend yield0.8%
- Financial periodQ2 2026
- RevenueKRW 478.47B
- Net incomeKRW 19.99B
- Free cash flow-KRW 18.05B
- Gross margin29.4%
Valuation Snapshot
latest market cap is KRW 874.89B; dividend yield is 0.8%.
Peer valuation comparison
Latest dividend yield is 0.8% versus a Healthcare sector median of 2.4% (66.7% below).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 874.89B | n/a | 0.8% | 500 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 500 KRW, yield 0.8%.
About Chong Kun Dang Pharmaceutical Corp.
Chong Kun Dang Pharmaceutical Corp. manufactures, markets, and sells medicines in South Korea and internationally. It offers prescription drugs for anti-hypertension, anti-hyperlipidaemia, and anti-diabetics, as well as immunosuppressants; over-the-counter medicines; and consumer health products, such as insecticides and hair dye products, as well as health supplements. The company was founded in 1941 and is headquartered in Seoul, South Korea.
ETFs that hold Chong Kun Dang Pharmaceutical Corp.
US-listed ETFs
Chong Kun Dang Pharmaceutical Corp. is held by 21 US-listed ETFs, going by the latest portfolios they filed with the SEC. The 8 most traded of them:
| ETF | Weight | Fee |
|---|---|---|
| iShares Core MSCI Emerging Markets ETF (IEMG) | <0.01% | 0.09% |
| Vanguard FTSE Developed Markets Index Fund ETF Shares (VEA) | <0.01% | 0.03% |
| Vanguard Total International Stock Index Fund ETF Shares (VXUS) | <0.01% | 0.05% |
| Vanguard Total World Stock Index Fund ETF Shares (VT) | <0.01% | 0.06% |
| Avantis Emerging Markets Equity ETF (AVEM) | <0.01% | 0.33% |
| Vanguard FTSE Pacific Index Fund ETF Shares (VPL) | <0.01% | 0.07% |
| Vanguard FTSE All-World ex-US Small-Cap Index Fund ETF Shares (VSS) | 0.01% | 0.06% |
| Dimensional Emerging Core Equity Market ETF (DFAE) | <0.01% | 0.29% |
Portfolios as filed with the SEC on Form N-PORT, dated May to July 2026. Brokers in the EU generally do not offer US-listed ETFs to retail investors.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Chong Kun Dang Pharmaceutical Corp.'s market cap?
Chong Kun Dang Pharmaceutical Corp.'s market capitalization is KRW 874.89B.
Does Chong Kun Dang Pharmaceutical Corp. pay a dividend?
Chong Kun Dang Pharmaceutical Corp. has a dividend yield of 0.8%.
What does Chong Kun Dang Pharmaceutical Corp. do?
Chong Kun Dang Pharmaceutical Corp. manufactures, markets, and sells medicines in South Korea and internationally. It offers prescription drugs for anti-hypertension, anti-hyperlipidaemia, and anti-diabetics, as well as immunosuppressants; over-the-counter medicines; and consumer health products, such as insecticides and hair dye products, as well as health supplements. The company was founded in 1941 and is headquartered in Seoul, South Korea.